In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor. | J Natl Cancer Inst;91(2): 163-8, 1999 Jan 20. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor.

le Coutre, P; Mologni, L; Cleris, L; Marchesi, E; Buchdunger, E; Giardini, R; Formelli, F; Gambacorti-Passerini, C.

Affiliation

le Coutre P; Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.

J Natl Cancer Inst ; 91(2): 163-8, 1999 Jan 20.

Article in En | MEDLINE | ID: mdl-9923858

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Experimental / Fusion Proteins, bcr-abl / Enzyme Inhibitors / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Natl Cancer Inst Year: 1999 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Protein-Tyrosine Kinases / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Experimental / Fusion Proteins, bcr-abl / Enzyme Inhibitors / Antineoplastic Agents Limits: Animals / Humans Language: En Journal: J Natl Cancer Inst Year: 1999 Document type: Article Affiliation country: Country of publication: